Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP344 | DOI: 10.1530/endoabs.37.EP344

15 views


1Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland; 2Department and Clinic of Endocrinology and Diabetology for Children and Adolescents, Wroclaw Medical University, Wroclaw, Poland.


Brown adipose tissue metabolism is of remarkable pathophysiological interest, because it could be a target for future therapies for obesity and metabolic syndrome. Irisin (Ir), recently identified novel adipomyokine is essential in a white-to-brown fatty tissue transdifferentiation, and mediates some of the positive influences on metabolic disorders through increase of energy expenditure. The exact regulation of Ir secretion and action is unknown but significant positive associations of circulating Ir with GHs and IGF1 were found. We studied Ir response in a group of patients treated with supraphysiological doses of GH (rGH). The study group consisted of 36 Turner syndrome (TS) patients aged 3.2–16.07 years (mean 8.2 years) diagnosed by karyotyping. The rGH was applied in a dose 0.05 mg/kg per day Prior to and following the treatment (mean 1.47±0.89 years) anthropometrical data were recorded as well as biochemical parameters were measured: Ir, OGTT, insulin,IGF1, and IGFBP3. The increase of IGF1 concentration at the end of observation was significant (from 119.4±62.46 to 413.37±204.38 ng/ml, mean±S.D., P=0.000). The significant rise of Ir level was recorded on rGH treatment (2.1±1.03 vs 2.47±0.79 μg/ml, mean±S.D., P=0.035). The rGH treatment influenced insulin resistance revealed by increased HOMA values (median 0.64±0.45 before and 0.92±0.97 after, P=0.02). The correlation between Ir and IGF1 levels was not significant neither before nor on the treatment (P=0.22 and P=0.95 respectively). The correlation between Ir and insulin (r=0.44, P=0.01) and Ir and HOMA (r=0.46, P=0.007) was significant. Result of the study showed an increase in Ir level following GH application. It seems to be not IGF1 mediated. Ir may mediate some metabolic effects of GH treatment. We are unable to conclude whether Ir rise is connected with direct GH stimulation, their influence of body composition, or with altered insulin sensitivity.

Article tools

My recent searches

No recent searches.